We are live on ! Find out more
MP

Mangrove Partners Portfolio holdings

AUM $1.24B
1-Year Est. Return 41.74%
This Fund
S&P 500
This Quarter Est. Return
-0.28%
1 Year Est. Return
+41.74%
3 Year Est. Return
+169.22%
5 Year Est. Return
+150.23%
10 Year Est. Return
+417.9%
AUM
$415M
AUM Growth
+$53.2M
Cap. Flow
+$6.09M
Cap. Flow %
1.47%
Top 10 Hldgs %
51.96%
Holding
55
New
14
Increased
13
Reduced
3
Closed
13

Sector Composition

Rank Sector Weight
1 Real Estate 22.12%
2 Financials 17.23%
3 Energy 8%
4 Communication Services 4.95%
5 Healthcare 4.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FUR
51
DELISTED
WINTHROP REALTY TRUST SHS BENE INT (NEW)
FUR
-883,014
Closed -$13.8M
COV
52
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
-120,000
Closed -$12.3M
AGN
53
DELISTED
Allergan Inc
AGN
-90,702
Closed -$19.3M

Similar funds

Mangrove Partners's Q1 2015 Portfolio in Review

As of Q1 2015, Mangrove Partners held 55 positions worth $415M, up 15% from $362M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Mangrove Partners's Q1 2015 filing shows 14 new, 13 increased, 3 reduced and 13 closed positions. Its largest new stake was Eiger BioPharmaceuticals, Inc.: 2,222 shares worth $18.9M. The largest sale was Allergan Inc, an estimated $19.3M.

By sector, the portfolio is most concentrated in Real Estate at 22% of assets, down from 27% a quarter earlier, followed by Financials and Energy.

  • Mangrove Partners's largest Q1 2015 buy was Eiger BioPharmaceuticals, Inc.: 2,222 shares worth $18.9M.
  • Mangrove Partners added most to Atlantic Power Corporation in Q1 2015, an estimated $13.6M increase.
  • Mangrove Partners's biggest Q1 2015 reduction was Ready Capital, cutting an estimated $1.43M.
  • Mangrove Partners fully exited Allergan Inc in Q1 2015, selling an estimated $19.3M.
  • Mangrove Partners's ten largest holdings make up 52% of its $415M portfolio in Q1 2015.
  • Mangrove Partners opened 14 new positions and closed 13 in Q1 2015.
  • Mangrove Partners's portfolio value rose 15% quarter-over-quarter to $415M.

Based on Mangrove Partners's 13F filing for Q1 2015, filed 15 May 2015.